Vericel (VCEL) Operating Margin (2011 - 2026)
Vericel's (VCEL) quarterly Operating Margin came in at 11.79% in Q1 2026, up 1254.0% year-on-year from 0.87% in Q1 2025, and down 148.85% quarter-over-quarter from 24.12% in Q4 2025.
Vericel (VCEL) Operating Margin (2011 - 2026) Analysis & Trends
Vericel has disclosed Operating Margin across 16 years of filings, most recently posting 11.79% for Q1 2026.
- Operating Margin for Q1 2026 came in at 11.79%, up 1254.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.4% (up 658.0% YoY), and the FY2025 annual result was 4.0%, up 209.0% from the prior year.
- Operating Margin came in at 11.79% for Q1 2026 at Vericel, down from 24.12% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 24.52% in Q4 2024 to a low of 24.52% in Q2 2022.
- The 5-year median for Operating Margin is 11.09% (2023), against an average of 5.13%.
- Across the five-year window, Operating Margin tumbled 1508 bps in 2022 and jumped 1254 bps in 2026, its largest moves.
- Vericel's Operating Margin stood at 11.55% in 2022, then soared by 70 bps to 19.59% in 2023, then advanced by 25 bps to 24.52% in 2024, then retreated by 2 bps to 24.12% in 2025, then slumped by 149 bps to 11.79% in 2026.
- The last three Operating Margin figures came in at 11.79% (Q1 2026), 24.12% (Q4 2025), and 5.11% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | -11.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.79% |
| Dec 31, 2025 | 24.12% |
| Sep 30, 2025 | 5.11% |
| Jun 30, 2025 | -3.21% |
| Mar 31, 2025 | -24.32% |
| Dec 31, 2024 | 24.52% |
| Sep 30, 2024 | -4.26% |
| Jun 30, 2024 | -11.45% |
| Mar 31, 2024 | -10.66% |
| Dec 31, 2023 | 19.59% |
| Sep 30, 2023 | -11.09% |
| Jun 30, 2023 | -12.98% |
| Mar 31, 2023 | -19.94% |
| Dec 31, 2022 | 11.55% |
| Sep 30, 2022 | -17.61% |
| Jun 30, 2022 | -24.52% |
| Mar 31, 2022 | -20.29% |
| Dec 31, 2021 | 8.70% |
| Sep 30, 2021 | -14.38% |
| Jun 30, 2021 | -9.44% |